Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Watts

Showing results (21-30 of 829) with videos related to

Pageof 83
Sort By:
QJM : Monthly Journal of the Association of Physicians|March 1, 2006
Apolipoproteins as markers and managers of coronary riskD C Chan, G F Watts
Clinical Laboratory|September 8, 2006
Recent advances in the investigation of lipoprotein metabolism using tracer methodologyDick C Chan, Gerald F Watts
The Review of Diabetic Studies : RDS|January 1, 2014
Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trialsSandra J Hamilton, Gerald F Watts
Current Opinion in Lipidology|January 19, 2016
The hinterland of familial hypercholesterolaemia: what do we not know?Anthony S Wierzbicki, Gerald F Watts
Clinical Therapeutics|November 10, 2015
Contemporary and Novel Therapeutic Options for HypertriglyceridemiaDamon A Bell, Gerald F Watts
The Medical Journal of Australia|September 2, 2016
Progress in the care of familial hypercholesterolaemia: 2016Damon A Bell, Gerald F Watts
Cardiology Clinics|April 4, 2018
Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?Katrina L Ellis, Gerald F Watts
Drugs|September 16, 2015
Challenges in the Diagnosis and Treatment of Homozygous Familial HypercholesterolemiaMatthew K Ito, Gerald F Watts
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2015
Evolocumab in the treatment of dyslipidemia: pre-clinical and clinical pharmacologyMichael M Page, Gerald F Watts
Clinical Chemistry|January 1, 1995
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage diseaseM H Cummings, G F Watts
Pageof 83

Showing results (21-30 of 829) with videos related to

Sort By:
Pageof 83
QJM : Monthly Journal of the Association of Physicians|March 1, 2006
Apolipoproteins as markers and managers of coronary riskD C Chan, G F Watts
Clinical Laboratory|September 8, 2006
Recent advances in the investigation of lipoprotein metabolism using tracer methodologyDick C Chan, Gerald F Watts
The Review of Diabetic Studies : RDS|January 1, 2014
Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trialsSandra J Hamilton, Gerald F Watts
Current Opinion in Lipidology|January 19, 2016
The hinterland of familial hypercholesterolaemia: what do we not know?Anthony S Wierzbicki, Gerald F Watts
Clinical Therapeutics|November 10, 2015
Contemporary and Novel Therapeutic Options for HypertriglyceridemiaDamon A Bell, Gerald F Watts
The Medical Journal of Australia|September 2, 2016
Progress in the care of familial hypercholesterolaemia: 2016Damon A Bell, Gerald F Watts
Cardiology Clinics|April 4, 2018
Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?Katrina L Ellis, Gerald F Watts
Drugs|September 16, 2015
Challenges in the Diagnosis and Treatment of Homozygous Familial HypercholesterolemiaMatthew K Ito, Gerald F Watts
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2015
Evolocumab in the treatment of dyslipidemia: pre-clinical and clinical pharmacologyMichael M Page, Gerald F Watts
Clinical Chemistry|January 1, 1995
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage diseaseM H Cummings, G F Watts
Pageof 83